|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option | $ 1.45 | 12/01/2020 | A | 465,000 | 12/01/2021(2) | 11/30/2030 | Common Stock | 465,000 | $ 0 | 465,000 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Maddux Randy Joe C/O IBIO, INC. 8800 HSC PARKWAY BRYAN, TX 77807 |
Chief Operating Officer |
/s/ Randy Maddux | 12/02/2020 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Consists of 309,000 shares of iBio, Inc. (the "Company") common stock , $0.001 par value per share (the "Common Stock") represented by 309,000 restricted stock units ("RSUs") granted under the Company's 2018 Omnibus Equity Incentive Plan, as amended (the "2018 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 309,000 RSUs start vesting pro rata on the (i) first anniversary of the grant date; (ii) second anniversary of the grant date; and (iii) third anniversary of the grant date. |
(2) | The options vest as follows: (i) 25% of the options granted under the 2018 Plan will vest after one year of employment with the Company; and (ii) after one year of employment with the Company, 6.25% of the options granted will vest for each additional three (3) months of employment. |